[Myocardial disease due to external cause].
Okada
Yoshinobu
Y
Department of Internal Medicine, Niigata Cancer Center Hospital.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000428:Alcohol Drinking / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018943:Anthracyclines / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D009206:Myocardium / Q000473:pathology; D011379:Prognosis; D013695:Temperance
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin